Daily physical activity, even at light intensities, linked to lower cancer risk
In a prospective cohort study of more than 85,000 adults in the United Kingdom, researchers…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Research discovers a way to slow or block recurrence of glioblastoma
Researchers at The University of Texas Health Science Centre at San Antonio have discovered a…
Two studies explore impact of pandemic on colorectal cancer screening and diagnosis
Two recent studies by researchers from Regenstrief Institute and the Indiana University School of Medicine…
Removing a protein ‘signal jammer’ improves immunotherapy
Targeted inhibition of a “signal jammer” protein may improve how tumours respond to immunotherapy. Published…
FDA approves pembrolizumab for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)
On March 19, 2025, the Food and Drug Administration granted traditional approval to pembrolizumab with…
Earliest stages and possible new cause of stomach cancer revealed
For the first time, scientists have systematically analysed somatic mutations in stomach lining tissue to…
Isoleucyl-tRNA synthetase 2 (IARS2) promotes pancreatic ductal adenocarcinoma (PDAC)
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment…
Uniquely shaped, fast-heating nanoparticles halt ovarian tumour growth
New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a…
High levels of traumatic stress found in caregivers of adult cancer patients
Every year, millions of family members and friends provide care for loved ones undergoing cancer…
CRG-based classification model for IDH1-mutant gliomas
Glioma, the most common primary malignant tumour of the central nervous system, presents significant clinical…